Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 Diabetes

NCT02984605 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-12-07

No results posted yet for this study

Summary

This study evaluates the nutritional meal replacement and individualized exercise prescription intervention on overweight and obese type 2 diabetes mellitus. Half of participants will receive nutritional meal replacement and individualized exercise prescription on the basis of conventional glucose-lowering treatment, while the other half will only receive conventional glucose-lowering treatment.

Conditions

Interventions

DIETARY_SUPPLEMENT

nutritional meal replacement

1 times a day with bags of nutritional meal replacement + individualized exercise prescription

Sponsors & Collaborators

  • Shanghai University of Sports National Science Park

    collaborator UNKNOWN
  • Yinhang Community Health Service Center of Yangpu District

    collaborator UNKNOWN
  • Dinghai Community Health Service Center of Yangpu District

    collaborator UNKNOWN
  • Kongjiang Community Health Service Center of Yangpu District

    collaborator UNKNOWN
  • Daqiao Community Health Service Center of Yangpu District

    collaborator UNKNOWN
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Ming Cui, MD · YinXing Community Health Service Center of Yangpu District

  • Wenbin Liu, MD · Dinghai Community Health Service Center of Yangpu District

  • Xiaoyi Che, MD · Kongjiang Community Health Service Center of Yangpu District

  • Hui Liu, MD · Daqiao Community Health Service Center of Yangpu District

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2018-12-31
Completion
2020-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02984605 on ClinicalTrials.gov